article · Statistics Optimization & Information Computing
Prostate cancer is a major health concern, and accurate risk prediction is essential for effective treatment. This paper presents a novel hybrid model combining near sets and soft sets to enhance prostate cancer risk assessment. By integrating artificial intelligence with medical data, our model captures uncertainties and provides more precise, personalized risk evaluations. Experiments focusing on key clinical factors, such as age and PSA levels, demonstrate significant improvements in early detection and treatment decisions. This research highlights the potential of hybrid AI models to improve patient care and outcomes in oncology.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.19139/soic-2310-5070-2382
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.